Resistin Is a Key Mediator of Glucose-dependent Insulinotropic Polypeptide (GIP) Stimulation of Lipoprotein Lipase (LPL) Activity in Adipocytes
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Studies on the physiological roles of the incretin hormone, glucose-dependent insulinotropic polypeptide (GIP) have largely focused on its insulinotropic action and ability to regulate beta-cell mass. In previous studies on the stimulatory effect of GIP on adipocyte lipoprotein lipase (LPL), a pathway was identified involving increased phosphorylation of protein kinase B (PKB) and reduced phosphorylation of LKB1 and AMP-activated protein kinase (AMPK). The slow time of onset of the responses suggested that GIP may have induced release of an intermediary molecule, and the current studies focused on the possible contribution of the adipokine resistin. In differentiated 3T3-L1 adipocytes, GIP, in the presence of insulin, increased resistin secretion through a pathway involving p38 mitogen-activated protein kinase (p38 MAPK) and the stress-activated protein kinase/Jun amino-terminal kinase (SAPK/JNK). The other major incretin hormone, glucagon-like peptide-1 (GLP-1), exhibited no significant effects. Chronic elevation of circulating GIP levels in the Vancouver Diabetic Fatty (VDF) Zucker rat resulted in increases in circulating resistin levels and activation of p38 MAPK or SAPK/JNK in epididymal fat tissue, suggesting the existence of identical pathways in vivo as well as in vitro. Administration of resistin to 3T3-L1 adipocytes mimicked the effects of GIP on the PKB/LKB1/AMPK/LPL pathway: increasing phosphorylation of PKB, reducing levels of phosphorylated LKB1 and AMPK, and increasing LPL activity. Knockdown of resistin using RNA interference attenuated the effect of GIP on the PKB/LKB1/AMPK/LPL pathway in 3T3-L1 adipocytes, supporting a role for resistin as a mediator.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“GIP promotes lipogenesis and lipid deposition under conditions of hyperinsulinema [34–36] while stimulating lipolysis and fatty acid oxidation under conditions of normo- or hypoinsulinemia [37–39].”
From Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes (2024) · cites this paper as [35]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
The biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Inhibition of gastric inhibitory polypeptide signaling prevents obesity
Miyawaki, K., Yamada, Y., Ban, N., Ihara, Y., Tsukiyama, K., Zhou, H., Fujimoto, S., Oku, A., Tsuda, K., Toyokuni, S., et al. (2002) · Nature Medicine · doi:10.1038/nm727 · Cited by 963
Regulation of Fasted Blood Glucose by Resistin
Banerjee, R. R., Rangwala, S. M., Shapiro, J. S., Rich, A. S., Rhoades, B., Qi, Y., Wang, J., Rajala, M. W., Pocai, A., Scherer, P. E., et al. (2004) · Science · doi:10.1126/science.1092341 · Cited by 725
The role of gut hormones in glucose homeostasis
Drucker, D. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30076 · Cited by 614
A Cysteine-rich Adipose Tissue-specific Secretory Factor Inhibits Adipocyte Differentiation
Kim, K.-H., Lee, K., Moon, Y. S., & Sul, H. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100028200 · Cited by 583
Savage, D. B., Sewter, C. P., Klenk, E. S., Segal, D. G., Vidal-Puig, A., Considine, R. V., & O’Rahilly, S. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2199 · Cited by 572
Brubaker, P. L., & Drucker, D. J. (2004) · Endocrinology · doi:10.1210/en.2004-0015 · Cited by 540
International Union of Pharmacology. XXXV. The Glucagon Receptor Family
Mayo, K. E., Miller, L. J., Bataille, D., Dalle, S., Göke, B., Thorens, B., & Drucker, D. J. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.6 · Cited by 506
Way, J. M., Görgün, C. Z., Tong, Q., Uysal, K. T., Brown, K. K., Harrington, W. W., Oliver, W. R., Willson, T. M., Kliewer, S. A., & Hotamisligil, G. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100189200 · Cited by 411
Role of resistin in diet-induced hepatic insulin resistance
Muse, E. D., Obici, S., Bhanot, S., Monia, B. P., McKay, R. A., Rajala, M. W., Scherer, P. E., & Rossetti, L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421270 · Cited by 372
Regulation of Resistin Expression and Circulating Levels in Obesity, Diabetes, and Fasting
Rajala, M. W., Qi, Y., Patel, H. R., Takahashi, N., Banerjee, R., Pajvani, U. B., Sinha, M. K., Gingerich, R. L., Scherer, P. E., & Ahima, R. S. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1671 · Cited by 351
Calabro, P., Samudio, I., Willerson, J. T., & Yeh, E. T. H. (2004) · Circulation · doi:10.1161/01.cir.0000147825.97879.e7 · Cited by 331
Alvarez, E., Martínez, M. D., Roncero, I., Chowen, J. A., García‐Cuartero, B., Gispert, J. D., Sanz, C., Vázquez, P., Maldonado, A., De Cáceres, J., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02914.x · Cited by 305
Insulin stimulates both leptin secretion and production by rat white adipose tissue
Barr, V. A., Malide, D., Zarnowski, M. J., Taylor, S. I., & Cushman, S. W. (1997) · Endocrinology · doi:10.1210/endo.138.10.5451 · Cited by 297
Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure
Hansotia, T., Maida, A., Flock, G., Yamada, Y., Tsukiyama, K., Seino, Y., & Drucker, D. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci25483 · Cited by 290
Glucagon-like peptide 1(GLP-1) in biology and pathology
Meier, J. J., & Nauck, M. A. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.538 · Cited by 288
Activation of SOCS-3 by Resistin
Steppan, C. M., Wang, J., Whiteman, E. L., Birnbaum, M. J., & Lazar, M. A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.4.1569-1575.2005 · Cited by 281
Kim, S.-J., Winter, K., Nian, C., Tsuneoka, M., Koda, Y., & McIntosh, C. H. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500540200 · Cited by 241
Self-citationFunctional GIP Receptors Are Present on Adipocytes
Yip, R. G.-C., Boylan, M. O., Kieffer, T. J., & Wolfe, M. M. (1998) · Endocrinology · doi:10.1210/endo.139.9.6288 · Cited by 237
Activation of Lipoprotein Lipase by Glucose-dependent Insulinotropic Polypeptide in Adipocytes
Kim, S.-J., Nian, C., & McIntosh, C. H. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609088200 · Cited by 216
Self-citationAdipokine resistin promotes in vitro angiogenesis of human endothelial cells
MU, H., OHASHI, R., YAN, S., CHAI, H., YANG, H., LIN, P., YAO, Q., & CHEN, C. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.01.015 · Cited by 210
Comparative studies of resistin expression and phylogenomics in human and mouse
Yang, R.-Z., Huang, Q., Xu, A., McLenithan, J. C., Eison, J. A., Shuldiner, A. R., Alkan, S., & Gong, D.-W. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.093 · Cited by 205
Nyberg, J., Anderson, M. F., Meister, B., Alborn, A.-M., Ström, A.-K., Brederlau, A., Illerskog, A.-C., Nilsson, O., Kieffer, T. J., Hietala, M. A., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4920-04.2005 · Cited by 191
Bornstein, S. R., Abu-Asab, M., Glasow, A., Päth, G., Hauner, H., Tsokos, M., Chrousos, G. P., & Scherbaum, W. A. (2000) · Diabetes · doi:10.2337/diabetes.49.4.532 · Cited by 189
Oben, J., Morgan, L., Fletcher, J., & Marks, V. (1991) · Journal of Endocrinology · doi:10.1677/joe.0.1300267 · Cited by 188
Gastric Inhibitory Polypeptide
Brown, J. C. (1982) · Monographs on endocrinology · doi:10.1007/978-3-642-81771-7 · Cited by 171 · cited 1×
“During a meal, GIP is secreted in response to long chain fatty acids (FAs) released from triglycerides (TGs) (16,17).”
BackgroundWang, B., & Trayhurn, P. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0055-8 · Cited by 163
Effect of gastric inhibitory polypeptide on plasma levels of chylomicron triglycerides in dogs.
Wasada, T., McCorkle, K., Harris, V, Kawai, K., Howard, B., & Unger, R. H. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110335 · Cited by 153
Shen, Y. H., Zhang, L., Gan, Y., Wang, X., Wang, J., LeMaire, S. A., Coselli, J. S., & Wang, X. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511105200 · Cited by 148
McTernan, P. G., Kusminski, C. M., & Kumar, S. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000217899.59820.9a · Cited by 148
Regulation of fatty acid uptake and metabolism in L6 skeletal muscle cells by resistin
Palanivel, R., & Sweeney, G. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.08.011 · Cited by 111
Resistin is expressed in pancreatic islets
Minn, A. H., Patterson, N. B., Pack, S., Hoffmann, S. C., Gavrilova, O., Vinson, C., Harlan, D. M., & Shalev, A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.061 · Cited by 102
Tappenden, K. A., Thomson, A. B. R., Wild, G. E., & McBurney, M. I. (1996) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607196020005357 · Cited by 101
Montrose‐Rafizadeh, C., Yang, H. M., Wang, Y., Roth, J., Montrose, M. H., & Adams, L. G. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199709)172:3<275::aid-jcp1>3.0.co;2-l · Cited by 94
Beck, B., & Max, J. (1983) · Regulatory Peptides · doi:10.1016/0167-0115(83)90276-8 · Cited by 91
Gut Peptides: Biochemistry and Physiology
Rehfeld, J. F. (1994) · Gut · doi:10.1136/gut.35.12.1774 · Cited by 88
Resistin induces insulin resistance in pancreatic islets to impair glucose-induced insulin release
Nakata, M., Okada, T., Ozawa, K., & Yada, T. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.134 · Cited by 81
Ort, T., Arjona, A. A., MacDougall, J. R., Nelson, P. J., Rothenberg, M. E., Wu, F., Eisen, A., & Halvorsen, Y.-D. C. (2005) · Endocrinology · doi:10.1210/en.2004-1421 · Cited by 74
McIntosh, C. H. S., Bremsak, I., Lynn, F. C., Gill, R., Hinke, S. A., Gelling, R., Nian, C., McKnight, G., Jaspers, S., & Pederson, R. A. (1999) · Endocrinology · doi:10.1210/endo.140.1.6464 · Cited by 73
Self-citationThe Encyclopedia of Endocrine Diseases
Gerver, W. J. M. (2004) · Cited by 73
Lee, M.-J., & Fried, S. K. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600065-jlr200 · Cited by 71
The metabolic role of GIP: physiology and pathology
Morgan, L. (1996) · Biochemical Society Transactions · doi:10.1042/bst0240585 · Cited by 66
Maebuchi, M., Machidori, M., Urade, R., Ogawa, T., & Moriyama, T. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(03)00279-0 · Cited by 61
Pereira, R. I., & Draznin, B. (2005) · Metabolism · doi:10.1016/j.metabol.2005.07.002 · Cited by 52
Endothelin-1 inhibits resistin secretion in 3T3-L1 adipocytes
Zhong, Q., Lin, C.-Y., Clarke, K. J., Kemppainen, R. J., Schwartz, D. D., & Judd, R. L. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00882-3 · Cited by 44
Leptin biosynthetic pathway in white adipocytes
Cammisotto, P., Bukowiecki, L. J., Deshaies, Y., & Bendayan, M. (2006) · Biochemistry and Cell Biology · doi:10.1139/o06-032 · Cited by 36
Resistin promotes 3T3-L1 preadipocyte differentiation
Gong, H., Ni, Y., Guo, X., Fei, L., Pan, X., Guo, M., & Chen, R. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500885 · Cited by 34
Chen, X., Kelemen, S. E., & Autieri, M. V. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00322.2004 · Cited by 26
Pravenec, M., Kazdová, L., Cahová, M., Landa, V., Zı́dek, V., Mlejnek, P., Šimáková, M., Wang, J., Qi, N., & Kurtz, T. W. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803237 · Cited by 19
Response of gastric inhibitory polypeptide to fat ingestion in normal dogs
Ohneda, A., Kobayashi, T., & Nihei, J. (1984) · Regulatory Peptides · doi:10.1016/0167-0115(84)90167-8 · Cited by 14
GIP (Gastric Inhibitory Polypeptide)
Pederson, R. A., & McIntosh, C. H. S. (2004) · Elsevier eBooks · doi:10.1016/b0-12-475570-4/00528-x · Cited by 7 · cited 1×
“During a meal, GIP is secreted in response to long chain fatty acids (FAs) released from triglycerides (TGs) (16,17).”
BackgroundSelf-citation
Research works printed but not linked: 3
- Pederson, 2004, 2, 202
- Skurk, 2007, Endocrinology, 92, 1023
- Roh, 2000, Am. J. Physiol., 279, E893
Cited by
Incretin hormones: Their role in health and disease
Nauck, M. A., & Meier, J. J. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13129 · Cited by 950
The role of incretins in glucose homeostasis and diabetes treatment
Kim, W., & Egan, J. M. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000604 · Cited by 824
“…AMP-activated protein kinase phosphorylation in differentiated 3T3-L1, cultured subcutaneous human adipocytes, and epidermal fat tissue of the VDF Zucker rat (Kim et al., 2007b) and these effects of GIP are mediated through the direct regulation of adipokine resistin release (Kim et al., 2007c).”
BackgroundResultGIP and GLP-1, the two incretin hormones: Similarities and differences
Seino, Y., Fukushima, M., & Yabe, D. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00022.x · Cited by 746
Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
Finan, B., Ma, T., Ottaway, N., Müller, T. D., Habegger, K. M., Heppner, K. M., Kirchner, H., Holland, J., Hembree, J., Raver, C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007218 · Cited by 696
Cardiovascular Biology of the Incretin System
Ussher, J. R., & Drucker, D. J. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1052 · Cited by 530
Metadata
- Authors
- Kim, S.-J., Nian, C., & McIntosh, C. H. S.
- Affiliations
- University of British Columbia (CA)
- Corresponding author
- McIntosh, Christopher H.S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 282
- Issue
- 47
- Pages
- 34139-34147
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2057235055
- Cited by
- 118
- References
- 55
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 5 · 2023: 2 · 2022: 5 · 2021: 6 · 2020: 1 · 2019: 4 · 2018: 8 · 2017: 5 · 2016: 5 · 2015: 3 · 2014: 4 · 2013: 8 · 2012: 12
- FWCI
- 7.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4708 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- resistin, glucose-dependent insulinotropic polypeptide, lipoprotein lipase, adipocytes, p38 MAPK, SAPK/JNK, Akt, LKB1, AMPK, incretins, glucagon-like peptide-1, 3T3-L1 adipocytes, adipokines, insulin signaling, epididymal adipose tissue
- MeSH terms
- AMP-Activated Protein Kinase Kinases, Animals, Enzyme Activation, Epididymis, Gastric Inhibitory Polypeptide, Insulin, Lipoprotein Lipase, Male, Multienzyme Complexes, Rats, Zucker, Second Messenger Systems, 3T3 Cells, Protein Serine-Threonine Kinases, Adipocytes, MAP Kinase Signaling System, RNA Interference, p38 Mitogen-Activated Protein Kinases, MAP Kinase Kinase 4, Insulin-Secreting Cells, Proto-Oncogene Proteins c-akt, Mice, Rats, Glucagon-Like Peptide 1, Resistin, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.